康哲药业(00867)接获新交所有关建议第二上市的上市资格函

智通财经
27 Jun

智通财经APP讯,康哲药业(00867)发布公告,于2025年6月25日,公司接获新交所有关建议第二上市的上市资格函,待当中所载条件达成后,预期股份将于2025年7月15日前后在新交所上市并开始买卖。上市资格函并非为建议第二上市、集团及╱或股份之优劣判断。

建议第二上市将不涉及增发新股,其后股份将继续于香港联合交易所有限公司作主要上市及买卖。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10